Dr. Omar Abdel-Rahman, MD - Ain Shams University

Risk of selected gastrointestinal toxicities in cancer patients treated with MEK inhibitors: a comparative systematic review and meta-analysis.

Authors:

Omar Abdel-Rahman Hesham ElHalawani Hoda Ahmed Mahmoud Ellithy

Expert Rev Gastroenterol Hepatol 2015 12;9(11):1433-45. Epub 2015 Sep 12.

a 1 Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Download full-text PDF	Source
http://dx.doi.org/10.1586/17474124.2015.1087847	DOI Listing

August 2016

8 Reads

2 Citations

2.550 Impact Factor

Risk of cutaneous toxicities in patients with solid tumors treated with immune checkpoint inhibitors: a meta-analysis.

Authors:

Omar Abdel-Rahman Hesham ElHalawani Mona Fouad

Future Oncol 2015 14;11(17):2471-84. Epub 2015 Aug 14.

Medical Microbiology & Immunology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.2217/fon.15.118	DOI Listing

June 2016

47 Reads

8 Citations

2.480 Impact Factor

Proteinuria in Patients with Solid Tumors Treated with Ramucirumab: A Systematic Review and Meta-Analysis.

Authors:

Omar Abdel-Rahman Hesham ElHalawani

Chemotherapy 2014 18;60(5-6):325-33. Epub 2015 Aug 18.

Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1159/000437253	DOI Listing

April 2016

34 Reads

2 Citations

1.554 Impact Factor

Risk of oral and gastrointestinal mucosal injury in patients with solid tumors treated with everolimus, temsirolimus or ridaforolimus: a comparative systematic review and meta-analysis.

Authors:

Omar Abdel-Rahman Mona Fouad

Expert Rev Anticancer Ther 2015 20;15(7):847-58. Epub 2015 May 20.

Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1586/14737140.2015.1047350	DOI Listing

April 2016

31 Reads

2 Citations

2.250 Impact Factor

Use of angiotensin-converting enzyme inhibitors in the prophylaxis of anthracycline or trastuzumab-related cardiac dysfunction: preclinical and clinical considerations.

Authors:

Omar Abdel-Rahman Mohamed Alorabi

Expert Rev Anticancer Ther 2015 26;15(7):829-37. Epub 2015 May 26.

Ain Shams University, Clinical oncology department, Faculty of medicine, Cairo, Egypt.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1586/14737140.2015.1047766	DOI Listing

April 2016

7 Reads

1 Citation

2.250 Impact Factor

Systemic therapy options for advanced gastrointestinal stromal tumors beyond first-line imatinib: a systematic review.

Authors:

Omar Abdel-Rahman Mona Fouad

Future Oncol 2015 ;11(12):1829-43

Medical Microbiology & Immunology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.2217/fon.15.33	DOI Listing

March 2016

6 Reads

1 Citation

2.480 Impact Factor

Targeting FGF receptors in colorectal cancer: from bench side to bed side.

Authors:

Omar Abdel-Rahman

Future Oncol 2015 ;11(9):1373-9

View Article

Download full-text PDF	Source
http://dx.doi.org/10.2217/fon.15.38	DOI Listing

February 2016

6 Reads

2 Citations

2.480 Impact Factor

Risk of fatal pulmonary events in patients with advanced non-small-cell lung cancer treated with EGF receptor tyrosine kinase inhibitors: a comparative meta-analysis.

Authors:

Omar Abdel-Rahman Hesham Elhalawani

Future Oncol 2015 ;11(7):1109-22

Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.2217/fon.15.16	DOI Listing

February 2016

43 Reads

2 Citations

2.480 Impact Factor

Immune checkpoints aberrations and gastric cancer; assessment of prognostic value and evaluation of therapeutic potentials.

Authors:

Omar Abdel-Rahman

Crit Rev Oncol Hematol 2016 Jan 10;97:65-71. Epub 2015 Aug 10.

Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Electronic address:

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.critrevonc.2015.08.015	DOI Listing

January 2016

2 Reads

7 Citations

4.030 Impact Factor

Risk of oral and gastrointestinal mucosal injury in patients with solid tumors treated with ramucirumab: a systematic review and meta-analysis.

Authors:

Omar Abdel-Rahman Hesham ElHalawani

Expert Opin Drug Saf 2015 Oct 27;14(10):1495-506. Epub 2015 Aug 27.

a Ain Shams University, Clinical Oncology Department, Faculty of Medicine , Lotfy Elsayed Street, Cairo 11665, Egypt +20 33 028 656 ;

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1517/14740338.2015.1074677	DOI Listing

October 2015

33 Reads

1 Citation

2.911 Impact Factor

Systemic therapy options for malignant pleural mesothelioma beyond first-line therapy: a systematic review.

Authors:

Omar Abdel-Rahman Mohamed Kelany

Expert Rev Respir Med 2015 Oct 7;9(5):533-49. Epub 2015 Sep 7.

a Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1586/17476348.2015.1083426	DOI Listing

October 2015

30 Reads

1 Citation

Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

Authors:

L Citrome

Int J Clin Pract 2015 Sep 6;69(9):978-97. Epub 2015 Aug 6.

New York Medical College, Valhalla, NY, USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1111/ijcp.12714	DOI Listing

September 2015

61 Reads

10 Citations

2.570 Impact Factor

Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancers.

Authors:

Hesham ElHalawani Omar Abdel-Rahman

Ther Clin Risk Manag 2015 28;11:1123-32. Epub 2015 Jul 28.

Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.2147/TCRM.S71045	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524527	PMC

August 2015

41 Reads

1 Citation

1.343 Impact Factor

Combination of transarterial chemoembolisation (TACE) plus antivirals for the management of hepatitis B-related hepatocellular carcinoma: A systematic review of the literature.

Authors:

Mona Fouad Omar Abdel-Rahman

Arab J Gastroenterol 2015 Jun 22;16(2):40-5. Epub 2015 Apr 22.

Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Electronic address:

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ajg.2015.03.003	DOI Listing

June 2015

6 Reads

Risk of mucocutaneous toxicities in patients with solid tumors treated with lapatinib: a systematic review and meta-analysis.

Authors:

Omar Abdel-Rahman Mona Fouad

Curr Med Res Opin 2015 May;31(5):975-86

Clinical Oncology Department, Faculty of Medicine, Ain Shams University , Cairo , Egypt.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1185/03007995.2015.1020367	DOI Listing

May 2015

15 Reads

2 Citations

2.653 Impact Factor

Risk of selected gastrointestinal toxicities in patients with advanced non-small cell lung cancer receiving erlotinib: a systematic review and meta-analysis.

Authors:

Omar Abdel-Rahman Mona Fouad

Expert Rev Anticancer Ther 2015 Apr 9;15(4):465-75. Epub 2015 Feb 9.

Faculty of Medicine, Clinical Oncology Department, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1586/14737140.2015.1014035	DOI Listing

April 2015

46 Reads

1 Citation

2.250 Impact Factor

Hedgehog pathway aberrations and gastric cancer; evaluation of prognostic impact and exploration of therapeutic potentials.

Authors:

Omar Abdel-Rahman

Tumour Biol 2015 Mar 14;36(3):1367-74. Epub 2015 Feb 14.

Clinical Oncology Department, Faculty of Medicine, Ain shams University, Cairo, Egypt,

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s13277-015-3216-6	DOI Listing

March 2015

6 Reads

6 Citations

2.840 Impact Factor

Revisiting oxaliplatin-based regimens for advanced hepatocellular carcinoma.

Authors:

Omar Abdel-Rahman

Curr Oncol Rep 2014 ;16(8):394

Faculty of Medicine, Ain Shams University, Cairo, Egypt,

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s11912-014-0394-0	DOI Listing

January 2015

15 Reads

3 Citations

2.891 Impact Factor

Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: a systematic review of the literature.

Authors:

Omar Abdel-Rahman Mona Fouad

Crit Rev Oncol Hematol 2014 Jul 7;91(1):1-8. Epub 2014 Jan 7.

Medical Microbiology and Immunology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.critrevonc.2013.12.013	DOI Listing

July 2014

34 Reads

14 Citations

4.030 Impact Factor

Risk of mucocutaneous toxicities in patients with solid tumors treated with sorafenib: an updated systematic review and meta-analysis.

Authors:

Omar Abdel-Rahman Mona Fouad

Expert Rev Anticancer Ther 2014 Jun 26;14(6):751-60. Epub 2014 Mar 26.

Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1586/14737140.2014.894465	DOI Listing

June 2014

2 Reads

1 Citation

2.250 Impact Factor

Sorafenib versus capecitabine in the management of advanced hepatocellular carcinoma.

Authors:

Omar Abdel-Rahman Manal Abdel-Wahab Mohammed Shaker Sherif Abdel-Wahab Mohammed Elbassiony Mahmoud Ellithy

Med Oncol 2013 4;30(3):655. Epub 2013 Jul 4.

Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Lofty Elsayed Street, Abbaseya, Cairo, Egypt.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s12032-013-0655-z	DOI Listing

April 2014

50 Reads

9 Citations

2.060 Impact Factor

Sorafenib for Egyptian patients with advanced hepatocellular carcinoma; single center experience.

Authors:

Omar Abdel-Rahman Manal Abdelwahab Mohammed Shaker Sherif Abdelwahab Mohammed Elbassiony Mahmoud Ellithy

J Egypt Natl Canc Inst 2014 Mar 16;26(1):9-13. Epub 2013 Sep 16.

Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Abbaseya Square, Cairo, Egypt.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jnci.2013.08.003	DOI Listing

March 2014

28 Reads

Systemic therapy for hepatocellular carcinoma (HCC): from bench to bedside.

Authors:

Omar Abdel-Rahman

J Egypt Natl Canc Inst 2013 Dec 21;25(4):165-71. Epub 2013 Sep 21.

Clinical Oncology Department, Ain Shams University, Egypt. Electronic address:

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jnci.2013.08.002	DOI Listing

December 2013

7 Reads

5 Citations

Combination transarterial chemoembolization plus sorafenib for unresectable hepatocellular carcinoma;a systematic review of the literature

View Article

September 2013

17 Reads

Dr. Omar Abdel-Rahman